Peter Repiščák
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
-
- CRISPR and Genetic Engineering 2
- Peroxisome Proliferator-Activated Receptors 1
- Epigenetics and DNA Methylation 1
- Ubiquitin and proteasome pathways 1
-
- Prostate Cancer Treatment and Research 6
- Co-authors
- Martin J. Paterson (4 shared papers)Stefan Erhardt (3 shared papers)Graham Rena (2 shared papers)I. Galbraith (1 shared paper)Hing Y. Leung (5 shared papers)Rachana Patel (6 shared papers)Mark J. Salji (4 shared papers)Ernest Mui (4 shared papers)
- Journals
- EMBO Molecular Medicine (1 paper)EJNMMI Research (1 paper)Clinical Cancer Research (1 paper)Life Science Alliance (1 paper)Cell Reports Medicine (1 paper)
- Partner nations
- United KingdomAustriaFinland
In The Last Decade
Peter Repiščák
13 papers receiving 415 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 97
- Aging 6
- Molecular Biology 213
- Immunology 41
- Biochemistry 13
Countries citing papers authored by Peter Repiščák
This map shows the geographic impact of Peter Repiščák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Repiščák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Repiščák more than expected).
Fields of papers citing papers by Peter Repiščák
This network shows the impact of papers produced by Peter Repiščák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Repiščák. The network helps show where Peter Repiščák may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Repiščák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 121 | |
| 2 | 2016 | 92 | |
| 3 | 2016 | 48 | |
| 4 | 2014 | 45 | |
| 5 | 2021 | 25 | |
| 6 | 2018 | 21 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 15 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 7 | |
| 12 | 2025 | 1 | |
| 13 | Targeting cholesterol transport in castration-resistant prostate cancer | 2018 | 1 |
About Peter Repiščák
Peter Repiščák is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Oncology, having authored 13 papers that have together received 422 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers), CRISPR and Genetic Engineering (2 papers), Acute Myeloid Leukemia Research (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), Organic Electronics and Photovoltaics (1 paper), Epigenetics and DNA Methylation (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (97 citations), Aging (6 citations), Molecular Biology (213 citations), Immunology (41 citations) and Biochemistry (13 citations). Peter Repiščák has collaborated with scholars based in United Kingdom, Austria and Finland. Frequent co-authors include Martin J. Paterson, Stefan Erhardt, Graham Rena, I. Galbraith, Hing Y. Leung, Rachana Patel, Mark J. Salji, Ernest Mui, Ann Hedley and Lisa Logie. Their work appears in journals such as EMBO Molecular Medicine, EJNMMI Research, Clinical Cancer Research, Life Science Alliance and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.